XTRA:MED

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

MEDICLIN Aktiengesellschaft operates hospitals in Germany.


Snowflake Analysis

Good value with moderate growth potential.

Share Price & News

How has MEDICLIN's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MED has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

1.5%

MED

1.3%

DE Healthcare

1.5%

DE Market


1 Year Return

-20.5%

MED

-1.2%

DE Healthcare

-1.8%

DE Market

Return vs Industry: MED underperformed the German Healthcare industry which returned -1.7% over the past year.

Return vs Market: MED underperformed the German Market which returned -0.7% over the past year.


Shareholder returns

MEDIndustryMarket
7 Day1.5%1.3%1.5%
30 Day-2.5%2.3%4.3%
90 Day-7.0%26.2%25.1%
1 Year-20.5%-20.5%-0.9%-1.2%0.2%-1.8%
3 Year-32.2%-33.3%-24.3%-26.7%1.3%-6.9%
5 Year15.1%13.1%-8.1%-12.3%15.0%-0.2%

Price Volatility Vs. Market

How volatile is MEDICLIN's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MEDICLIN undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MED (€3.96) is trading below our estimate of fair value (€47.82)

Significantly Below Fair Value: MED is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MED is poor value based on its PE Ratio (34.5x) compared to the Healthcare industry average (21.3x).

PE vs Market: MED is poor value based on its PE Ratio (34.5x) compared to the German market (20.7x).


Price to Earnings Growth Ratio

PEG Ratio: MED is good value based on its PEG Ratio (0.7x)


Price to Book Ratio

PB vs Industry: MED is good value based on its PB Ratio (1x) compared to the DE Healthcare industry average (1.4x).


Next Steps

Future Growth

How is MEDICLIN forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

49.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MED's forecast earnings growth (49.2% per year) is above the savings rate (0.2%).

Earnings vs Market: MED's earnings (49.2% per year) are forecast to grow faster than the German market (22.2% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MED's revenue (4.2% per year) is forecast to grow slower than the German market (5.8% per year).

High Growth Revenue: MED's revenue (4.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MED's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has MEDICLIN performed over the past 5 years?

-24.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MED has a large one-off gain of €9.6M impacting its March 31 2010 financial results.

Growing Profit Margin: MED's current net profit margins (0.8%) are lower than last year (1%).


Past Earnings Growth Analysis

Earnings Trend: MED's earnings have declined by -24.8% per year over the past 5 years.

Accelerating Growth: MED's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MED had negative earnings growth (-16.8%) over the past year, making it difficult to compare to the Healthcare industry average (9.7%).


Return on Equity

High ROE: MED's Return on Equity (2.9%) is considered low.


Next Steps

Financial Health

How is MEDICLIN's financial position?


Financial Position Analysis

Short Term Liabilities: MED's short term assets (€163.7M) exceed its short term liabilities (€152.1M).

Long Term Liabilities: MED's short term assets (€163.7M) do not cover its long term liabilities (€553.4M).


Debt to Equity History and Analysis

Debt Level: MED's debt to equity ratio (53%) is considered high.

Reducing Debt: MED's debt to equity ratio has increased from 34.6% to 53% over the past 5 years.

Debt Coverage: MED's debt is well covered by operating cash flow (73%).

Interest Coverage: MED's interest payments on its debt are not well covered by EBIT (0.5x coverage).


Balance Sheet


Next Steps

Dividend

What is MEDICLIN current dividend yield, its reliability and sustainability?

1.26%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MED's dividend (1.26%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.28%).

High Dividend: MED's dividend (1.26%) is low compared to the top 25% of dividend payers in the German market (3.82%).


Stability and Growth of Payments

Stable Dividend: MED's dividend payments have been volatile in the past 10 years.

Growing Dividend: MED's dividend payments have not increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (43.5%), MED's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: MED's dividends in 3 years are forecast to be well covered by earnings (18.2% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.5yrs

Average management tenure


CEO

Volker Hippler (50yo)

4.25yrs

Tenure

Mr. Volker Hippler has been Chairman of Management Board at MEDICLIN Aktiengesellschaft since April 1, 2016 and has been its CEO since April 2016. Mr. Hippler worked in a consulting company focussing on he ...


Leadership Team

NamePositionTenureCompensationOwnership
Volker Hippler
Chairman of Management Board & CEO4.25yrsno datano data
Tino Fritz
CFO & Member of the Management Board1.83yrsno datano data
Mario Waidele
Head of Group Accountingno datano datano data
Ralf Bürgy
Head of Internal Audit0.50yrno datano data
Katja Kiesewetter
Head of Law0.50yrno datano data
Gabriele Eberle
Head of Corporate Communications & Press Spokeswoman0.50yrno datano data
Jörg Störmer
Head of Purchasing & Medical Technology0.50yrno datano data
Carin Emminghaus
Head of Payroll & Application Management0.50yrno datano data
Frank Heuberger
Head of Finance & Accounting0.50yrno datano data
Bärbel Merz
Head of Group Controlling0.50yrno datano data

0.5yrs

Average Tenure

Experienced Management: MED's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Brigitte Mohn
Member of Advisory Boardno datano datano data
Hans Hilpert
Deputy Chairman of Supervisory Board18.17yrsno datano data
Günter Neubauer
Member of Advisory Boardno datano datano data
Michael Bock
Member of the Supervisory Board15.17yrs€14.25kno data
Andreas Tecklenburg
Member of Advisory Boardno datano datano data
Axel Ekkernkamp
Member of Advisory Boardno datano datano data
Walburga Erichsmeier
Employee Representative Member of Supervisory Board7.83yrs€12.26kno data
Winfried Gleitze
Member of Advisory Boardno datano datano data
Thomas Muller
Employee Representative Member of Supervisory Board7.83yrs€12.00kno data
Jan Liersch
Chairman of the Supervisory Board0.67yrno datano data

7.8yrs

Average Tenure

Experienced Board: MED's board of directors are considered experienced (7.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

MEDICLIN Aktiengesellschaft's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MEDICLIN Aktiengesellschaft
  • Ticker: MED
  • Exchange: XTRA
  • Founded:
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €188.100m
  • Shares outstanding: 47.50m
  • Website: https://www.mediclin.de

Number of Employees


Location

  • MEDICLIN Aktiengesellschaft
  • Okenstrasse 27
  • Offenburg
  • Baden-Württemberg
  • 77652
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MEDDB (Deutsche Boerse AG)YesBearer SharesDEEURDec 2000
MEDXTRA (XETRA Trading Platform)YesBearer SharesDEEURDec 2000
0NDGLSE (London Stock Exchange)YesBearer SharesGBEURDec 2000

Biography

MEDICLIN Aktiengesellschaft operates hospitals in Germany. It operates through Post-Acute, Acute, and Other Activities segments. The Post-Acute segment offers services in the fields of subsequent nursing and curative treatments. This segment’s subsequent nursing treatment includes various medical measures required to facilitate the healing process and return the patient to a functioning state after acute care treatment; and curative treatment comprises prophylactic measures against the occurrence or reoccurrence of illnesses. The Acute segment provides medical services focusing on neurology and neurological early rehabilitation, as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. This segment also offers services in the areas of cardiology, oncology, and ENT, as well as acute outpatient services. The Other Activities segment offers full-time and short-term nursing care; and outpatient nursing care services. As of December 31, 2018, the company operated 36 clinics, 7 nursing care facilities, 3 home nursing care services, and 9 medical care centers with a total capacity of approximately 8,300 beds in 11 German federal states. MEDICLIN Aktiengesellschaft is headquartered in Offenburg, Germany. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/07/01 21:08
End of Day Share Price2020/07/01 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.